Gabriela Prucnal
Research Subjects
Research Interests
Gabriela Prucnal has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Rakoczy
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
6 shared publications - Jowita Frydrych
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
6 shared publications - Karolina Ochyra
Medical Center in Łańcut, Łańcut, Poland
6 shared publications - Karolina Ryba
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
6 shared publications - Katarzyna Znamirowska
University Teaching Hospital them. F. Chopin in Rzeszów, Rzeszów, Poland
6 shared publications - Klaudia Zacher
Medical Center in Łańcut, Łańcut, Poland
6 shared publications
Latest Publications
- Open Access
- 18 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
CARDIOFACIOCUTANEOUS SYNDROME (CFCS) IN THE LIGHT OF CONTEMPORARY RESEARCH - A REVIEW OF THE LITERATURE
The term RASopathies was introduced to describe a group of genetic syndromes that share similar phenotypic features and a common molecular basis. RASopathies are among the most numerous groups of recognized congenital developmental disorders. These syndromes have variable clinical courses, and the phenotypic features observed in newborns may differ from those seen in later stages of life - childhood, adolescence, or adulthood - which significantly complicates accurate clinical diagnosis. The underlying cause of these disorders involves mutations in genes encoding proteins associated with the Ras/MAPK (mitogen-activated protein kinase) signaling pathway. Cardiofaciocutaneous syndrome (CFCS) is a representative RASopathy, clinically defined by distinctive craniofacial dysmorphism, congenital heart defects, dermatological anomalies, postnatal growth retardation, and varying degrees of intellectual disability. Recent advances in molecular genetics have facilitated, at least to some extent, the differential diagnosis of CFCS, thereby improving diagnostic accuracy. Lifelong, multidisciplinary medical management is essential for both pediatric and adult patients, necessitating coordinated care involving specialists from various medical fields. This article focuses on the molecular pathogensis, clinical features, prenatal findings and recommended evaluations following initial diagnosis. Materials: We conducted a review and analysis of the literature available in the PubMed database, using keywords.
- 18 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessCARDIOFACIOCUTANEOUS SYNDROME (CFCS) IN THE LIGHT OF CONTEMPORARY RESEARCH - A REVIEW OF THE LITERATURE
The term RASopathies was introduced to describe a group of genetic syndromes that share similar phenotypic features and a common molecular basis. RASopathies are among the most numerous groups of recognized congenital developmental disorders. These syndromes have variable clinical courses, and the phenotypic features observed in newborns may differ from those seen in later stages of life - childhood, adolescence, or adulthood - which significantly complicates accurate clinical diagnosis. The underlying cause of these disorders involves mutations in genes encoding proteins associated with the Ras/MAPK (mitogen-activated protein kinase) signaling pathway. Cardiofaciocutaneous syndrome (CFCS) is a representative RASopathy, clinically defined by distinctive craniofacial dysmorphism, congenital heart defects, dermatological anomalies, postnatal growth retardation, and varying degrees of intellectual disability. Recent advances in molecular genetics have facilitated, at least to some extent, the differential diagnosis of CFCS, thereby improving diagnostic accuracy. Lifelong, multidisciplinary medical management is essential for both pediatric and adult patients, necessitating coordinated care involving specialists from various medical fields. This article focuses on the molecular pathogensis, clinical features, prenatal findings and recommended evaluations following initial diagnosis. Materials: We conducted a review and analysis of the literature available in the PubMed database, using keywords.
- Open Access
- 7 August 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 44, 62828
Management of opioid-induced constipation in palliative patients with disseminated cancer
Stool constipation is one of the most common afflictions affecting palliative patients with advanced cancer. The widespread use of opioids in the analgetic treatment of this group of patients exacerbates the already existing problem of constipation or is the underlying cause of its occurrence. Often, however, the etiology of the condition appears to be multifactorial. This article discusses the effects of opioids on the gastrointestinal tract as a cause of constipation, other possible causes of constipation in palliative patients, helpful definitions and how to diagnose constipation in this group of patients. Another important topic highlighted is the possibility of gastrointestinal obstruction and the possible management of its presence. Finally, the management of constipation is discussed, taking into account both non-pharmacological and pharmacological treatment with traditional laxatives and peripheral opioid receptor antagonists (naldemedine, naloxegol, methylnaltrexone). The article is based on an analysis of the available scientific literature and cited sources.
- 7 August 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 44, 62828
Open AccessManagement of opioid-induced constipation in palliative patients with disseminated cancer
Stool constipation is one of the most common afflictions affecting palliative patients with advanced cancer. The widespread use of opioids in the analgetic treatment of this group of patients exacerbates the already existing problem of constipation or is the underlying cause of its occurrence. Often, however, the etiology of the condition appears to be multifactorial. This article discusses the effects of opioids on the gastrointestinal tract as a cause of constipation, other possible causes of constipation in palliative patients, helpful definitions and how to diagnose constipation in this group of patients. Another important topic highlighted is the possibility of gastrointestinal obstruction and the possible management of its presence. Finally, the management of constipation is discussed, taking into account both non-pharmacological and pharmacological treatment with traditional laxatives and peripheral opioid receptor antagonists (naldemedine, naloxegol, methylnaltrexone). The article is based on an analysis of the available scientific literature and cited sources.
- Open Access
- 26 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 61225
Impact of physical activity on the development of dementia
Issues related to disease prevention are being increasingly addressed, particularly through the prevention of diseases by identification and verification of risk factors. One condition that is associated with an increasing incidence among the aging population is dementia, which places a burden on health care systems and the caregivers. The purpose of this studyis to explore the relationship between physical activity and the development of dementia based on the available literature. Understanding how exercise and sports can help prevent dementia may prove crucial in its prevention. Research indicates that physical activity has an impact on preventing and delaying the development of dementia by reducing cardiovascular risk factors and having a neuroprotective effect. However, the effectiveness of physical activity, the type of sport and environmental conditions plays a major role in this aspect. Notably, evidence suggests that contact sports and strenuous physical work can promote the development of dementia.
- 26 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 61225
Open AccessImpact of physical activity on the development of dementia
Issues related to disease prevention are being increasingly addressed, particularly through the prevention of diseases by identification and verification of risk factors. One condition that is associated with an increasing incidence among the aging population is dementia, which places a burden on health care systems and the caregivers. The purpose of this studyis to explore the relationship between physical activity and the development of dementia based on the available literature. Understanding how exercise and sports can help prevent dementia may prove crucial in its prevention. Research indicates that physical activity has an impact on preventing and delaying the development of dementia by reducing cardiovascular risk factors and having a neuroprotective effect. However, the effectiveness of physical activity, the type of sport and environmental conditions plays a major role in this aspect. Notably, evidence suggests that contact sports and strenuous physical work can promote the development of dementia.
- Open Access
- 20 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60935
The Adenomyosis and infertility - underestimated challenge in reproductive medicine
Introduction: Adenomyosis is considered as a chronic gynecological condition increasingly observed among women of reproductive age. It remains underdiagnosed and frequently underestimated as a contributing factor in fertility disorders. Characterized by the presence of endometrial glands and stroma within the myometrium, adenomyosis causes progressive structural and functional uterine changes that may impair endometrial receptivity and disrupt implantation. Aim of the study: This review aims to summarize current knowledge on the effects of adenomyosis on fertility. It focuses on the pathophysiological mechanisms involved, diagnostic tools, classification systems.. It explores the pathophysiological mechanisms that contribute to impaired reproductive outcomes, as well as available diagnostic methods that enable an effective identification of the condition. Materials and methodology:The literature review includes articles from databases (PubMed), selected to their citation, using keywords “adenomyosis”, “infertility” Conclusion: Adenomyosis is increasingly recognized as a potential contributing factor to female infertility. Anatomical and functional alterations within the uterus may impair embryo implantation and early pregnancy development. Current evidence highlights the importance of including adenomyosis in the diagnostic work-up and management of infertile patients. A deeper understanding of its underlying mechanisms may lead to more effective and individualized treatment strategies.
- 20 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60935
Open AccessThe Adenomyosis and infertility - underestimated challenge in reproductive medicine
Introduction: Adenomyosis is considered as a chronic gynecological condition increasingly observed among women of reproductive age. It remains underdiagnosed and frequently underestimated as a contributing factor in fertility disorders. Characterized by the presence of endometrial glands and stroma within the myometrium, adenomyosis causes progressive structural and functional uterine changes that may impair endometrial receptivity and disrupt implantation. Aim of the study: This review aims to summarize current knowledge on the effects of adenomyosis on fertility. It focuses on the pathophysiological mechanisms involved, diagnostic tools, classification systems.. It explores the pathophysiological mechanisms that contribute to impaired reproductive outcomes, as well as available diagnostic methods that enable an effective identification of the condition. Materials and methodology:The literature review includes articles from databases (PubMed), selected to their citation, using keywords “adenomyosis”, “infertility” Conclusion: Adenomyosis is increasingly recognized as a potential contributing factor to female infertility. Anatomical and functional alterations within the uterus may impair embryo implantation and early pregnancy development. Current evidence highlights the importance of including adenomyosis in the diagnostic work-up and management of infertile patients. A deeper understanding of its underlying mechanisms may lead to more effective and individualized treatment strategies.
- Open Access
- 19 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60936
The Pain in Alzheimer's Disease – Diagnosis and Treatment - reports human trial data
Dementia diseases, led by Alzheimer's disease (AD), are among the most common and serious conditions affecting the elderly. The number of people suffering from Alzheimer's disease is increasing every year. Among these individuals, a significant portion experiences chronic pain, the diagnosis of which poses a major challenge due to communication difficulties with the patients suffering from Alzheimer's disease. The objective of this publication is to provide an overview of the available methods for diagnosing and treating pain in patients with Alzheimer’s disease. The article presents the studies that utilized neuroimaging diagnostics and scales used to assess the severity and impact of pain on daily functioning, as well as the medications used. Neuroimaging studies indicate that while pain pathways are preserved in the early stages of Alzheimer's disease, the response to pain stimuli diminishes in more advanced stages, potentially necessitating higher doses of analgesics in many AD patients. Effective treatment of chronic pain is crucial for improving the quality of life of patients, yet its diagnosis still presents many challenges due to communication difficulties with these individuals, the lack of precise scales, assessment methods, and the small number of individuals included in the studies.
- 19 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60936
Open AccessThe Pain in Alzheimer's Disease – Diagnosis and Treatment - reports human trial data
Dementia diseases, led by Alzheimer's disease (AD), are among the most common and serious conditions affecting the elderly. The number of people suffering from Alzheimer's disease is increasing every year. Among these individuals, a significant portion experiences chronic pain, the diagnosis of which poses a major challenge due to communication difficulties with the patients suffering from Alzheimer's disease. The objective of this publication is to provide an overview of the available methods for diagnosing and treating pain in patients with Alzheimer’s disease. The article presents the studies that utilized neuroimaging diagnostics and scales used to assess the severity and impact of pain on daily functioning, as well as the medications used. Neuroimaging studies indicate that while pain pathways are preserved in the early stages of Alzheimer's disease, the response to pain stimuli diminishes in more advanced stages, potentially necessitating higher doses of analgesics in many AD patients. Effective treatment of chronic pain is crucial for improving the quality of life of patients, yet its diagnosis still presents many challenges due to communication difficulties with these individuals, the lack of precise scales, assessment methods, and the small number of individuals included in the studies.
- Open Access
- 19 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 61118
The Role of Coenzyme Q10 Supplementation as a Potential Adjunct in the Treatment of Autoimmune Diseases
Autoimmune diseases are a heterogeneous group of afflictions whose etiopathogenesis is still incompletely understood. There is a great need to search for new treatment methods because of the difficulty of treatment, the numerous side effects of pharmacotherapy and the life-threatening complications associated with these diseases. The discovered role of mitochondrial dysfunction in the pathogenesis of these conditions and the associated oxidative stress, but also the contribution of coenzyme Q10 to normal mitochondrial function, provided the impetus for research into the use of coenzyme Q10 supplementation as an adjunctive therapy for autoimmune diseases. This review article summarises the role of coenzyme Q10 supplementation in the regulation of impaired processes involved in the pathogenesis of autoimmune diseases and focuses on the potential benefits of coenzyme Q10 supplementation for patients with autoimmune diseases.
- 19 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 61118
Open AccessThe Role of Coenzyme Q10 Supplementation as a Potential Adjunct in the Treatment of Autoimmune Diseases
Autoimmune diseases are a heterogeneous group of afflictions whose etiopathogenesis is still incompletely understood. There is a great need to search for new treatment methods because of the difficulty of treatment, the numerous side effects of pharmacotherapy and the life-threatening complications associated with these diseases. The discovered role of mitochondrial dysfunction in the pathogenesis of these conditions and the associated oxidative stress, but also the contribution of coenzyme Q10 to normal mitochondrial function, provided the impetus for research into the use of coenzyme Q10 supplementation as an adjunctive therapy for autoimmune diseases. This review article summarises the role of coenzyme Q10 supplementation in the regulation of impaired processes involved in the pathogenesis of autoimmune diseases and focuses on the potential benefits of coenzyme Q10 supplementation for patients with autoimmune diseases.